ELI LILLY & Co
LLYNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 20/3026% above fair value
$1410.99−6.55 (-0.46%)
Close on Nov 2, 2026Market cap $1.33TP/E 45.8Yield 0.44%
Eli Lilly Share repurchases by Year
Share repurchases — Shares repurchased (millions) (M)
Eli Lilly Share repurchases: 4.80M in FY2025, up 60.0% from a year earlier.
Latest, FY2025
4.80
Period ended Dec 31, 2025
Change on a year earlier
+60.0%
3 in FY2024
History
3 years
Since FY2023
Sources
1
Form 10-K (filed 2026-02-12)
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-12) ↗
Reported in Form 10-K Consolidated Statements of Shareholders' Equity.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Share repurchases — Shares repurchased (millions) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 4.80 | +60.0% | Form 10-K (filed 2026-02-12) ↗ |
| FY2024 | Dec 31, 2024 | 3 | +30.4% | Form 10-K (filed 2026-02-12) ↗ |
| FY2023 | Dec 31, 2023 | 2.30 | – | Form 10-K (filed 2026-02-12) ↗ |
Cite this data
StockData. (2026). Eli Lilly Share repurchases (M), annual FY2023–FY2025 [Data set]. Compiled from Eli Lilly SEC filings and investor materials. https://stockdatahq.com/stocks/lly/kpis/buyback-shares
See every metric in the Eli Lilly KPI table. Data updated Oct 25, 2026.